June 24 - MSB % of portfolio AND + or - %, page-55

Hi @Pharmagang,

thanks for posting the current MSB grant list & primary claims from the US examiners. Very timely.

Although the 'method' patents granted to Mesoblast in the US so far are, as all holders should know, commercially compelling, I have to say I've enjoyed reading the 'composition of matter' patents even more, because of their fundamental 'blackout-style' reservation to Mesoblast Ltd of all exploitation economic opportunities using that MSC composition in the US.

All 9 of the composition claim grants on your list above are worthwhile reading in full, IMO.

And the 'belt & braces' overlap of their fundamental operational scope in the US, without even starting to consider possible MSC utility, is IMO one of the better IP defensive structures I've seen in my own humble IP licensing practise years.

However, given the current furious 'argument' on HC: MSB with down-ramping non-holders who claim to know all about Mesoblast's patent portfolio, and the sheer quantity of crap that's being posted, I must admit I do have a (topical) favourite patent atm - yep, that's right its US9963678 B2 - and I feel sure that you already know why:



This US patent has been effective (retroactively) since its issue on May 8, 2018 i.e. 6 years ago. I wonder if people have been complying?

And, to add to your excellent post above & help avoid any further 'argument' (and untruths) about Mesoblast Ltd being published on Hot Copper, I'll point out in passing that Kind Code 'B2' confirms that grant in the records of the USPTO. I understand USPTO's been using them since 2001, so no excuse for CYP etc holders not to have done their research, eh.

Also, the 'B2' doesn't indicate any weakness in the grant - in fact, IMO, it is a stronger designation than B1 because it's reserved for grants of patent where there's been a previously published pre-grant publication i.e. additional notice pre-grant to the world at large to provide time for objections etc.

And yet the grant was still issued.

Food for thought everyone. Have a good one.

Cheers
GLTA(LT)H